Ten-Year incidence of chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors

Circulation

Volumn 127, Issue 10, 2013, Pages 1105-1115

  Sabino, Ester C ^a   Ribeiro, Antonio L ^b   Salemi, Vera M C ^a   Di Lorenzo Oliveira, Claudia ^c   Antunes, Andre P ^d   Menezes, Marcia M ^d   Ianni, Barbara M ^a   Nastari, Luciano ^a   Fernandes, Fabio ^a   Patavino, Giuseppina M ^e   Sachdev, Vandana ^f   Capuani, Ligia ^e   De Almeida Neto, Cesar ^e   Carrick, Danielle M ^g   Wright, David ^g   Kavounis, Katherine ^g   Goncalez, Thelma T ^h   Carneiro Proietti, Anna Barbara ^i,j   Custer, Brian ^h   Busch, Michael P ^h,j   Murphy, Edward L ^h,k   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^d Centro de Ciências Biológicas e da Saúde Prontosocor de Montes Claros   (Brazil)

^e Sangue Hemocentro de São Paulo   (Brazil)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g WESTAT   (United States)

^h BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

ⁱ Blood Systems Research Institute ^*  (Brazil)

^j Escola de Medicina   (Brazil)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

blood donors; Brazil; Chagas cardiomyopathy; Chagas disease; incidence

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; ATENOLOL; BENZNIDAZOLE; CAPTOPRIL; DIGOXIN; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE MONONITRATE; LOSARTAN; NIFURTIMOX; PROPRANOLOL; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ANAMNESIS; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD DONOR; CARDIOLOGIST; CHAGAS DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; HEART SOUND; HUMAN; INFECTION RISK; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRYPANOSOMA CRUZI;

ADULT; ASYMPTOMATIC DISEASES; BLOOD DONORS; BRAZIL; CHAGAS CARDIOMYOPATHY; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84874950032     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.123612     Document Type: Article

References (27)

1. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388-1402.
2. Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, Brutus L, Pialoux G. Chagas disease: changes in knowledge and management. Lancet Infect Dis. 2010;10:556-570.
3. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52: 1922-1930.
4. Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion. 2012;52:1901-1911.
5. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher-Moreno A, Sousa AS, Scanavacca MI. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355:799-808.
6. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115:1101-1108.
7. Maguire JH, Hoff R, Sherlock I, Guimarães AC, Sleigh AC, Ramos NB, Mott KE, Weller TH. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75:1140-1145.
8. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007;298:2171-2181.
9. Biolo A, Ribeiro AL, Clausell N. Chagas cardiomyopathy: where do we stand after a hundred years? Prog Cardiovasc Dis. 2010;52:300-316.
10. Salles NA, Sabino EC, Cliquet MG, Eluf-Neto J, Mayer A, Almeida-Neto C, Mendonça MC, Dorliach-Llacer P, Chamone DF, Saéz-Alquézar A. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors. Transfusion. 1996;36:969-973.
11. Saéz-Alquézar A, Otani MM, Sabino EC, Ribeiro-dos-Santos G, Salles N, Chamone DF. Evaluation of the performance of Brazilian blood banks in testing for Chagas' disease. Vox Sang. 1998;74: 228-231.
12. Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ, Greenland P. Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA. 2007;297:978-985.
13. Prineas RJ, Crow R.S., Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG; 1982.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57: 450-458.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
16. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165-193.
17. Maguire JH. Trypanosoma. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:2327-2334.
18. Rocha MO, Nunes MC, Ribeiro AL. Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz. 2009;104(suppl 1):159-166.
19. Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzmán S, Moreno Barral J, Caeiro TF, Madoery RJ, Salomone OA. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart. 2003;89: 1186-1190.
20. Pereira JB, Wilcox HP, Coura JR. The evolution of chronic chagasic cardiopathy, I: the influence of parasitemia [in Portuguese]. Rev Soc Bras Med Trop. 1992;25:101-108.
21. Beleigoli AM, Lima-Costa MF, Diniz Mde F, Ribeiro AL. B-type natriuretic peptide and anthropometric measures in a Brazilian elderly population with a high prevalence of Trypanosoma cruzi infection. Peptides. 2011;32:1787-1792.
22. Silva Sde A, Gontijo ED, Amaral CF. Case-control study of factors associated with chronic Chagas heart disease in patients over 50 years of age. Mem Inst Oswaldo Cruz. 2007;102:845-851.
23. Ferreira Ide L, Silva TP. Transmission elimination of Chagas' disease by Triatoma infestans in Brazil: an historical fact [in Portuguese]. Rev Soc Bras Med Trop. 2006;39:507-509.
24. Sarabanda AV, Marin-Neto JA. Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol. 2011;34: 54-62.
25. Ribeiro AL, Cavalvanti PS, Lombardi F, Nunes Mdo C, Barros MV, Rocha MO. Prognostic value of signal-averaged electrocardiogram in Chagas disease. J Cardiovasc Electrophysiol. 2008;19:502-509.
26. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol. 2007;18:1236-1240.
27. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S; BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J. 2008;156:37-43.